Virological breakthrough after immune checkpoint inhibitor and nucleos(t)ide analog treatment in patients with hepatitis B surface antigen positive hepatocellular carcinoma: a real-world study

ABSTRACT:

SUBMITTER: Wang K 

PROVIDER: S-EPMC8578995 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature